The Blackstone Group, a major US private equity firm, has announced the acquisition of Takeda Consumer Healthcare Company (TCHC), a subsidiary of Takeda Pharmaceutical. Investment funds and other industries have been putting out feelers toward the pharmaceutical sector in recent…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Record 101 Generics from 30 Companies Listed for Aricept
November 29, 2011
-
REGULATORY MHLW Says Sept Drug Price Settlement Rate Dips to 78.1%, Falling Below 2009 Level
November 28, 2011
-
REGULATORY CSIMC to Discuss Additional Price Cuts for Long-Listed Drugs
November 28, 2011
-
ORGANIZATION Economic Losses Due to Illness, Injury Total ¥3.3 Tril. Annually in Japan: ACCJ
November 28, 2011
-
REGULATORY DPJ's Subcommittee for PAL Amendment Begins Deliberations Nov. 28, to Compile Opinion by End-Jan
November 25, 2011
-
ORGANIZATION MSF Japan General Director Expresses Concern Over TPP Negotiations, Possible Generics Price Rise
November 25, 2011
-
REGULATORY Policy Screening Committee Proposes Major Cutbacks in Long-Listed Drug Prices, Additional Decreases Possible
November 24, 2011
-
BUSINESS 25 Leading Drug Makers Report Overall Decline in Sales, Profits in 1st Half
November 24, 2011
-
ACADEMIA JSMO Issues 33 Development Requests for Unapproved Drugs, Indications
November 22, 2011
-
BUSINESS Sanofi, Nichi-Iko to Copromote Latter's Generic Drugs
November 22, 2011
-
BUSINESS Sawai, Nichi-Iko Boost Inventory Ahead of Expected PAL Amendment
November 21, 2011
-
REGULATORY MHLW Study Group Postpones Decision on Relief System for Victims of Health Damages Due to Anticancer Drugs
November 21, 2011
-
REGULATORY After Delay, CSIMC Recommends Listing of Ilaris for Treatment of CAPS
November 21, 2011
-
ORGANIZATION 6 Indian Generics Companies Including Zydus Form Association, to Start Operations This Month
November 18, 2011
-
BUSINESS Teva to Merge Taiyo, Kowa-Teva, Establish “Teva Pharma Japan” in Mid-2012
November 18, 2011
-
BUSINESS Fujifilm, Kyowa Kirin to Set Up Joint Venture for Biosimilars in 2012
November 17, 2011
-
REGULATORY CSIMC Recommends Listing of 9 Products Including Imusera; Recommendation Put on Hold for Ilaris
November 17, 2011
-
REGULATORY High Court Turns Down Iressa Compensation Appeal
November 16, 2011
-
REGULATORY 7-Drug Rule Should Be Relaxed or Eliminated to Promote GE Name Prescribing: Dr Adachi of CSIMC
November 16, 2011
-
BUSINESS Japan’s Jul-Sep 2011 Ethical Drug Market Grows 7.7%: IMS Japan
November 15, 2011
ページ
Measures focusing on risk management should be necessary to prevent disruptions in API supplies, Prof. Hiroyuki Sakamaki of Kanagawa University…
Nearly a year after the introduction of the Ministry of Health, Labor and Welfare’s (MHLW) drug promotion guidelines in April…
Advancements in modified oligonucleotide technologies has been the key driver behind a spate of approvals in the oligonucleotide therapeutics space…
Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…
The Ministry of Health, Labor and Welfare (MHLW) on November 27 added to the NHI price list Japan’s first biosimilars of Avastin (bevacizumab), Nesp (darbepoetin alfa), and Forteo (teriparatide). The NHI prices of first biosimilars are set at 70% of…
A total of 51 new drugs joined the NHI price list in 2019, which are expected to generate combined peak sales of 373 billion yen, according to Jiho’s tally of data submitted to a key reimbursement policy panel. The relatively…
Some seven years in the making, Japan’s Ministry of Health, Labor and Welfare (MHLW) finally rolled out a cost-effectiveness assessment…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…
As we accelerate along the information superhighway, one thing is certain. At this moment, we have access to more knowledge at the click of a button than any other point in human history. It’s an exciting opportunity, especially within the…